Relaxin-2 as a promising biomarker of cardiometabolic diseases
Saved in:
| Date: | 2022 |
|---|---|
| Main Author: | O. A. Pankova |
| Format: | Article |
| Language: | English |
| Published: |
2022
|
| Series: | International medical journal |
| Online Access: | http://jnas.nbuv.gov.ua/article/UJRN-0001376916 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| Journal Title: | Library portal of National Academy of Sciences of Ukraine | LibNAS |
Institution
Library portal of National Academy of Sciences of Ukraine | LibNASSimilar Items
-
Chitotriosidase activity as additional biomarker in the diagnosis of lysosomal storage diseases
by: N. V. Olkhovych
Published: (2016) -
Pathogenetic aspects of early cardiometabolic therapy in patients with acute coronary syndrome with no-st segment elevation after percutaneus coronary intervention
by: O. O. Jakimenko, et al.
Published: (2015) -
Lipocalin as an informative biomarker in acute kidney injury
by: Ja. Kvasnevskij
Published: (2015) -
Transcriptome-based identification of PDGFA as a candidate secreted biomarker for hepatocellular carcinoma
by: M. S. Chesnokov, et al.
Published: (2016) -
Transcriptome-based identification of PDGFA as a candidate secreted biomarker for hepatocellular carcinoma
by: Chesnokov, M.S., et al.
Published: (2016)